© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
December 19, 2019
New findings show that Ibrance has the potential to help patients with brain metastases that harbor a CDK pathway alteration.
FDA’s Approval of Keytruda-Based Regimen for Certain Stomach Cancer Subtypes ‘Really Exciting’ For Patients
Heart Failure May Increase Cancer Risk
Easing Worried Patients During Difficult Times Throughout Cancer Treatment
A Trail of Crumbs